Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 10, 2013, Pages 1508-1517

  Ji, Bian Sheng ^a   Cen, Juan ^a   He, Ling ^b   Liu, Meng ^a   Liu, Yan Qing ^a   Liu, Lu ^a  

^a HENAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

oxygen glucose deprivation; P glycoprotein; rat brain microvessel endothelial cells; transendothelial transfer

Indexed keywords

ENDOTHELIN 1; MULTIDRUG RESISTANCE PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; RHODAMINE 123; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ELECTRIC RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MODULATION; NEUROLOGICAL AND SENSORIAL PROCEDURES; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; WESTERN BLOTTING;

OXYGEN GLUCOSE DEPRIVATION; P-GLYCOPROTEIN; RAT BRAIN MICROVESSEL ENDOTHELIAL CELLS; TRANSENDOTHELIAL TRANSFER;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL HYPOXIA; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; GLUCOSE; MICROSCOPY, FLUORESCENCE; MICROVESSELS; OXYGEN; P-GLYCOPROTEIN; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84883739758     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12122     Document Type: Article

References (38)

1. Cordon-Cardo C, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277-1287.
2. Elsinga PH, et al. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr Pharm Des 2004; 10: 1493-1503.
3. Spudich A, et al. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 2006; 9: 487-488.
4. Cen J, et al. Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats. J Pharm Pharmacol 2013; 65: 665-672.
5. He L, Ji BS,. In vitro and in vivo study of CJY, an isoflavone, on P-glycoprotein function in rats. J Chemother 2008; 3: 361-367.
6. Jeliazkova-Mecheva VV, Bobilya DJ,. A porcine astrocyte/endothelial cell co-culture model of the blood-brain barrier. Brain Res Brain Res Protoc 2003; 12: 91-98.
7. Cen J, et al. N(1)-(quinolin-2-ylmethyl)butane-1, 4-diamine, a polyamine analogue, attenuated injury in in vitro and in vivo models of cerebral ischemia. Int J Dev Neurosci 2012; 30: 584-595.
8. Rutten M, et al. Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res 1987; 425: 301-310.
9. Cen J, et al. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM. Eur J Pharmacol 2010; 647: 21-30.
10. Gaillard PJ, et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 2001; 12: 215-222.
11. Bauer B, et al. Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 2007; 71: 667-675.
12. Abbott NJ, et al. Structure and function of the blood-brain barrier. Neurobiol Dis 2009; 37: 13-25.
13. Scheffer GL, et al. Multidrug resistance related molecules in human and murine lung. J Clin Pathol 2002; 55: 332-339.
14. Thiebaut F, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987; 84: 7735-7738.
15. Schinkel AH, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491-502.
16. Cordon-Cardo C, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989; 86: 695-698.
17. Demeule M, et al. Isolation of Endothelial Cells from Brain, Lung, and Kidney: expression of the multidrug resistance P-Glycoprotein isoforms. Biochem Biophys Res Commun 2001; 281: 827-834.
18. Cisternino S, et al. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Pharm Res 2003; 20: 1607-1611.
19. Huang J, et al. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66: 232-245.
20. Akasaka Y, et al. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol 2006; 19: 588-598.
21. Kostulas N, et al. Increased IL-1{beta}, IL-8, and IL-17 mRNA Expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999; 30: 2174-2179.
22. Liu H, et al. Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci Biobehav Rev 2013; 37: 561-572.
23. Bian LG, et al. Increased endothelin-a in the rabbit model of meddle cerebral artery occlusion. Neurosci Lett 1994; 174: 47-50.
24. Dehouck MP, et al. Endothelin-1 as a mediator of endothelial cell pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab 1997; 17: 464-469.
25. Miller RD, et al. NMDA-and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow. J Neurol Sci 1996; 136: 37-40.
26. Kozlov AV, et al. Ex vivo demonstration of nitric oxide in the rat brain: effects of intrastriatal endothelin-1 injection. Neurosci Lett 1995; 196: 140-144.
27. Saadoun S, Garcia A,. Endothelin stimulates nitric oxide-dependent cyclic GMP formation in rat cerebellar astroglia. Neuroreport 1999; 10: 33-36.
28. Huber JD, et al. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001; 24: 719-725.
29. Kniesel U, Wolburg H,. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000; 20: 57-76.
30. Pardridge WM,. Molecular biology of the blood-brain barrier. Methods Mol Med 2003; 89: 385-399.
31. Andreeva AY, et al. Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 2001; 276: 38480-38486.
32. Krizbai IA, Deli MA,. Signalling pathways regulating the tight junction permeability in the blood-brain barrier. Cell Mol Biol (Noisy-le-grand) 2003; 49: 23-31.
33. Farshori P, Kachar B,. Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J Membr Biol 1999; 170: 147-156.
34. Tsukamoto T, Nigam SK,. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol Renal Physiol 1999; 276: F737-F750.
35. Sobue K, et al. Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 1999; 35: 155-164.
36. Hafny B, et al. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci Lett 1997; 236: 107-111.
37. Megard I, et al. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Res 2002; 927: 153-167.
38. Hartz AM, et al. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol 2006; 69: 462-670